Always® Returns to Coachella in Partnership with Secret® to Debut "The Refresh Room," Reimagining the Female Festival Bathroom Experience

QYOU Studios Wins "Most Innovative Studio" at the Digiday TV & Video Awards

National Permanente physician leaders to share insights on health care's future, new technology, and value-based care at Becker's 16th Annual Meeting

CooperVision Launches MADE BETTER™ Promise Beginning with MyDay® Contact Lenses*¹

Cetera Welcomes Veteran Commonwealth Advisor W. Michael Sanders

Dr. Nancy L. Lewisová byla jmenována novou vědeckou ředitelkou organizace Národní komplexní síť pro léčbu rakoviny (NCCN)

NORDIC PHARMA, INC. ERREICHT MIT DER BEHANDLUNG VON 100.000 PATIENTEN EINEN WICHTIGEN MEILENSTEIN. (USA) ERWEITERT SEIN ANGEBOT UND ERHÖHT DEN BEDIENUNGSKOMFORT, INDEM ES SEINEN LIEFERUNGEN VON LACRIFILL® KANALIKULÄRES GEL ZUR BEHANDLUNG TROCKENER AUGEN BEILEGT

MARKING MAJOR MILESTONE OF 100,000 PATIENTS TREATED, NORDIC PHARMA, INC. (U.S.) ENHANCES ITS OFFERING AND INCREASES PROVIDER CONVENIENCE BY INCLUDING CANNULAS WITH ITS SHIPMENTS OF LACRIFILL® CANALICULAR GEL FOR TREATMENT OF DRY EYE SYMPTOMS

Dr Nancy L. Lewis mianowana dyrektorką naukową NCCN

MARQUANT L'ÉTAPE IMPORTANTE DES 100 000 PATIENTS TRAITÉS, NORDIC PHARMA, INC. (U.S.) ÉLARGIT SON OFFRE ET AUGMENTE LA COMMODITÉ POUR LES PRESTATAIRES EN INCLUANT DES CANULES DANS SES LIVRAISONS DE GEL CANALICULAIRE LACRIFILL® POUR LE TRAITEMENT DES SYMPTÔMES DE LA SÉCHERESSE OCULAIRE.

Nancy L. Lewis, MD, MBS, FACP, sa stáva novou vedeckou riaditeľkou National Comprehensive Cancer Network (NCCN)

Nancy L. Lewis, MD, MBS, FACP, Named New Chief Scientific Officer for National Comprehensive Cancer Network (NCCN)

Доктор Нэнси Л. Льюис (Nancy L. Lewis), MBS, FACP, назначена новым главным научным сотрудником National Comprehensive Cancer Network (NCCN)

Nancy L. Lewis, MD, MBS, FACP, nommée directrice scientifique du National Comprehensive Cancer Network (NCCN)

Nancy L. Lewis, MD, MBS, FACP, nombrada directora científica de National Comprehensive Cancer Network

MySavant.ai Acquires Savant International to Scale AI-Driven Nearshore Operations Across Latin America

VERSABANK ANNOUNCES THE RESULTS OF ITS 2026 MEETING OF SHAREHOLDERS

DualityBio Announces China NMPA Acceptance of Biologics License Application Seeking Approval for Trastuzumab Pamirtecan for the Treatment of Unresectable or Metastatic HER2-Positive Adult Breast Cancer

El nuevo auto premium: una reciente encuesta de Mazda revela que la experiencia y el diseño son más importantes que la marca

Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual Meeting

EDGX launches first in-orbit demonstration of its AI computing system on SpaceX Transporter-16

Metro Health Care Costs Vary by More than Twofold Nationwide

Crocs, Inc. Announces Conference Call to Review First Quarter 2026 Earnings Results

Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg

Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results

Galmed Announces the Breakthrough Development of a Brain Penetrating New Formulation of its SCD1 inhibitor, Aramchol

Yadea va présenter de nouvelles solutions de mobilité électrique à la 139e foire de Canton

Abilitie, TED i St. Edward's University uruchamiają 12-tygodniowy kurs menedżerski Mini MBA

Rumænien vinder international anerkendelse, CAHM Europe modtager Green & Organic Award på den 57. udgave af Cosmoprof Worldwide Bologna

Cyngn Accelerates Autonomous Vehicle Adoption in 2026